Control of Burkholderia (Pseudomonas) bacteraemia in the intensive care and paediatric units

Journal of the College of Physicians and Surgeons Pakistan

Volumn 14, Issue 2, 2004, Pages 102-104

  Ahmad, Khurshid ^a,b   Khan, Umer Farooq ^a   Hafeez, Assad ^a  

^a KRL Hospital   (Pakistan)

^b NONE   (Pakistan)

Author keywords

Bacteraemia; Burkholderia; Hand hygiene; Nosocomial transmission

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPICILLIN; CEFOTAXIME; CEFRADINE; CEFTRIAXONE; CHLORAMPHENICOL; COTRIMOXAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASEPSIS; BACTEREMIA; BACTERIAL TRANSMISSION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BLOOD CULTURE; BURKHOLDERIA CEPACIA; GRAM NEGATIVE BACTERIUM; HAND WASHING; HOSPITAL HYGIENE; HOSPITAL INFECTION; HUMAN; INCUBATION TIME; INFECTION CONTROL; INSTRUMENT STERILIZATION; INTENSIVE CARE UNIT; NONHUMAN; PEDIATRICS; STRAIN DIFFERENCE;

BACTEREMIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTIONS; CROSS INFECTION; CROSS-SECTIONAL STUDIES; HANDWASHING; HOSPITAL UNITS; HUMANS; INTENSIVE CARE UNITS; PAKISTAN;

EID: 2342438404     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Goldmann DA, Klinger JD. Pseudomonas cepacia: biology, mechanism of virulence, epidemiology. J Paediatr 1986; 108: 806-12.
2. Holmes A, Govan J, Goldstein R. Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health. Emerg Infect Dis 1998; 4: 221-7.
3. Sobel JD, Hashman N, Reinherz G, Merzbach D. Nosocomial P. cepacia infection associated with chlorhexidine contamination. Am J Med 1982; 73:183-96.
4. Anderson RI, Vess RW, Panlilio AI, Favero MS. Prolonged survival of Pseudomonas cepacia in commercially manufactured povidone-iodine. Appl Environ Microbiol 1990; 56: 3598-600.
5. Baron EJ, Paterson LR, Finegold SM. Bailey and Scott's diagnostic microbiology, 9th ed. St. Louis: Mosby 1994.
6. Hafeez A, Mazhar F, Qureshi M, Ahmed K, Incidence of infection in peripheral intravenous cannulas. J Coll Physicians Surgeons Pak 2001; 11:421-3.
7. Vandepitte J, Engbaek K, Piot P, Heuck CC. Basic laboratory procedures in clinical bacteriology, Geneva: WHO 1991.
8. NCCLS. Performance standards for antimicrobial disc susceptibility tests, seventh informational supplement, 1997, NCCLS document M100 S7.
9. Centres for Disease Control and Prevention. Guidelines for hand hygiene in health care settings: recommendations of the healthcare infection control practices advisory committee and the HIC-PAC/SHEA/APIC/IDSA. Hand hygiene task force. Morb Mortal Wkly Rep 2002; 51: 1-45.
10. Gilardi GL. Pseudomonas. In: Lennette EH, Balows A, Hausler WJ, Shadomy HJ (edi). Manual of clinical microbiology. 4th ed. Washington DC; Am Soc Microbiol; 1985; 350-72.
11. Berkelman RI, Lewin S, Allen JR, Anderson RL, Budnick LD, Shapiro S, et al. Pseudobacteraemia attributed to contamination of povidone-iodine with P. cepacia. Ann Intern Med 1981; 95: 32-6.
12. Henderson DK, Baptiste R, Parrillo J, Gill VJ. Indolent epidemic of Pseudomonas cepacia bacteraemia and pseudobacteraemia in an intensive care unit traced to a contaminated blood gas analyzer. Am J Med 1988; 84: 75-81.
13. Phillips I, Eykin S, Curtis MA, Snell JJS. Pseudomonas cepacia (multivorans) septicaemia in an intensive care unit. Lancet 1971; 1: 375-7.
14. Jarvis WR, Olson D, Tablan O, Martone WJ. The epidemiology of nosocomial Pseudomonas cepacia infections: endemic infections. Eur J Epidemiol 1987; 3: 233-6.